The relationship between early recanalization and serum NT-proBNP levels in patients with a first ST-segment elevation myocardial infarction treated with primary coronary angioplasty.
OBJECTIVE
Primary coronary angioplasty (PCI) performed in the first hours after the onset of chest pain plays an important role in the prevention of death and heart failure after acute myocardial infarction (MI). Levels of circulating natriuretic peptides (BNP and NT-proBNP) reflect the severity of left ventricular (LV) dysfunction. The blood concentration of these peptides is increased in patients with MI. The aim of this study is to evaluate whether early PCI (< or = 3 hours) after onset of chest pain modulates NT-proBNP levels in patients with first ST-elevation acute MI.


RESULTS
Serum NT-proBNP levels were measured on hospital admission and 4 to 5 days post MI. Transthoracic echocardiography was performed on the 4th day after MI. We included 111 consecutive patients with first ST-elevation acute MI treated with PCI with stent implantation. In 55 patients (49.5%) PCI was performed within 3 hours after the onset of symptoms (the study group). Multivariate analysis revealed that only the time from the onset of chest pain to PCI and EF/WMI were independently associated with serum NT-proBNP > 105 pg/ml on admission. Only EF/WMI and evolution of non-Q myocardial infarction correlated with an NT-proBNP level > 388.5 pg/ml on discharge.


CONCLUSIONS
NT-proBNP concentration measured both on admission and 4 to 5 days after acute MI independently correlates with echocardiographic parameters of LV systolic function (EF and WMSI). One hour delay in PCI raises the risk of NT-proBNP level elevation on admission by 30%.
Szadkowska
Iwona
I
Invasive Cardiology Unit, Ist Department of Cardiology and Cardiosurgery, Medical University of Lodz, Poland. iwonakoska@interia.pl
Goch
Jan Henryk
JH
Polak
Lukasz
L
Stepień
Henryk
H
Chizyński
Krzysztof
K
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000800:Angioplasty, Balloon; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000503:physiopathology / Q000628:therapy; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors; D013318:Stroke Volume; D013997:Time Factors
D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain